Effect of Salt Substitution on Cardiovascular Events and Death
Bruce Neal(UNSW Sydney), Paul Elliott(Ipsen (France)), Jie Yu(Yangtze University), Nicole Li(George Institute for Global Health), Liping Huang(UNSW Sydney), Jingpu Shi(First Hospital of China Medical University), Sallie‐Anne Pearson(UNSW Sydney), Darwin R. Labarthe(UK Health Forum), Yi Zhao(Ningxia Medical University), Sandrine Stepien(The University of Sydney), Yangfeng Wu(Beijing Haidian Hospital), Maoyi Tian(Harbin Medical University), Lijing L. Yan(Duke University), Gian Luca Di Tanna(University of Bern), Ka‐Chun Li(The George Institute for Global Health), Faxuan Wang(Ningxia Medical University), Bing Ma(First Hospital of China Medical University), Bo Zhou, Ruijuan Zhang(China Women's University), Peifen Duan(Changzhi Medical College), Yuhong Zhang(Central Hospital of Zibo), Xinyi Zhang(Shenyang Agricultural University), Zhifang Li(Changzhi Medical College), Yan Yu(Xi'an Jiaotong University), Yishu Liu(Capital Medical University), Weiwei Shi(Tianjin University), Xiangxian Feng(Changzhi Medical College), Jianxin Zhang(Hebei Provincial Center for Disease Control and Prevention), Jixin Sun(Hebei Provincial Center for Disease Control and Prevention), Sana Shan(UNSW Sydney), Zhixin Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xuejun Yin(George Institute for Global Health)
Cited by 726
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k